A phase II study of two dose levels of ofatumumab induction followed by maintenance therapy in symptomatic, previously untreated chronic lymphocytic leukemia.
about
Safety and efficacy of Ofatumumab in chronic lymphocytic leukemia: a systematic review and meta-analysis.The use of ofatumumab in the treatment of B-cell malignancies.Current Treatment of Chronic Lymphocytic Leukemia.New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness.
P2860
A phase II study of two dose levels of ofatumumab induction followed by maintenance therapy in symptomatic, previously untreated chronic lymphocytic leukemia.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
A phase II study of two dose l ...... chronic lymphocytic leukemia.
@ast
A phase II study of two dose l ...... chronic lymphocytic leukemia.
@en
type
label
A phase II study of two dose l ...... chronic lymphocytic leukemia.
@ast
A phase II study of two dose l ...... chronic lymphocytic leukemia.
@en
prefLabel
A phase II study of two dose l ...... chronic lymphocytic leukemia.
@ast
A phase II study of two dose l ...... chronic lymphocytic leukemia.
@en
P2093
P2860
P50
P356
P1476
A phase II study of two dose l ...... chronic lymphocytic leukemia.
@en
P2093
Amy S Ruppert
David Waterhouse
Jeffrey A Jones
Steven Papish
William Harwin
P2860
P304
P356
10.1002/AJH.24468
P577
2016-07-07T00:00:00Z